> top > docs > PMC:7253235 > spans > 40530-41296 > annotations

PMC:7253235 / 40530-41296 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1376 84-94 Species denotes outpatient Tax:9606
1377 637-645 Species denotes patients Tax:9606
1390 63-69 Disease denotes cancer MESH:D009369
1391 207-213 Disease denotes cancer MESH:D009369
1392 338-346 Disease denotes COVID-19 MESH:C000657245
1393 547-552 Disease denotes tumor MESH:D009369

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T117 502-515 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T54 502-515 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T405 63-69 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T406 207-213 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T407 338-346 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T408 547-552 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T307 326-333 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T308 502-515 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T220 63-69 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T221 207-213 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T222 391-399 Phenotype denotes oncology http://purl.obolibrary.org/obo/HP_0002664
T223 400-408 Phenotype denotes oncology http://purl.obolibrary.org/obo/HP_0002664
T224 547-552 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T256 150-285 Sentence denotes • Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting
T257 286-346 Sentence denotes • Preoperative/procedural screening and testing for COVID-19
T258 347-445 Sentence denotes • Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic
T259 446-560 Sentence denotes • Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy
T260 561-679 Sentence denotes • Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible
T261 680-766 Sentence denotes • Consideration of minimizing surveillance/staging imaging during and after treatments